Capralogics

Capralogics is a private, revenue-generating service provider in the antibody discovery and production sector. Its core business is generating custom polyclonal antibodies and nanobodies for clients across academia, biotech, pharma, and diagnostics, functioning as a specialized CRO. The company holds key USDA and EU regulatory licenses, allowing it to export animal-derived products globally, which is a significant operational advantage. While not developing its own therapeutic pipeline, its services directly enable and accelerate the R&D programs of its partners, as evidenced by numerous citations in high-impact publications and patents.

Custom animal immunization for polyclonal antibody and camelid-derived nanobody (VHH) generation, supported by USDA and EU regulatory approvals for international export of animal-derived products.

Capralogics competes in the fragmented custom antibody services market against numerous other CROs and academic core facilities. Its key differentiators are its specialized focus on nanobody generation from camelids and its rare EU-approved exporter status for animal products. Competition includes larger, full-service CROs and technology platforms offering synthetic library-based discovery.